Immune Pharmaceuticals Inc.
IMNP
IMNP was delisted on the 25th of July, 2018.
12 hedge funds and large institutions have $573K invested in Immune Pharmaceuticals Inc. in 2015 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 4 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
0% more funds holding
Funds holding: 12 → 12 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
5% less capital invested
Capital invested by funds: $604K → $573K (-$31K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
+$104K |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$7.36K |
| 3 |
IFS
Ifrah Financial Services
Little Rock,
Arkansas
|
+$1.87K |
| 4 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$1.87K |
| 5 |
Goldman Sachs
New York
|
+$1.65K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$42K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$38K |
| 3 |
SIM
Spark Investment Management
New York
|
-$25K |
| 4 |
Citigroup
New York
|
-$150 |
| 5 |
Morgan Stanley
New York
|
-$150 |
IMNP Hedge Fund Activity: Q1 2015 in Review
12 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Immune Pharmaceuticals Inc. (IMNP) for Q1 2015, worth a combined $573K — down 5.1% from $604K a quarter earlier.
Fund positioning in IMNP was balanced in Q1 2015: 4 funds opened new positions, 4 closed out, 3 added to existing stakes and 2 trimmed.
The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $104K. The largest seller was Deutsche Bank, exiting entirely with an estimated $42K sold.
- 12 institutional investors held Immune Pharmaceuticals Inc. (IMNP) as of Q1 2015, unchanged from Q4 2014.
- Funds reported $573K of Immune Pharmaceuticals Inc. stock for Q1 2015, down 5.1% quarter-over-quarter.
- 4 funds opened new Immune Pharmaceuticals Inc. positions in Q1 2015 and 4 closed out, a net change of 0 holders.
- The largest Immune Pharmaceuticals Inc. buyer in Q1 2015 was Virtu KCG Holdings, an estimated $104K added.
- The largest Immune Pharmaceuticals Inc. seller in Q1 2015 was Deutsche Bank, an estimated $42K sold.
Based on aggregated 13F filings for Q1 2015.